Home  >  Products  >  THOC7 (THO complex 7 homolog (Drosophila) ) Blocking Peptide (the C terminal of THOC7)(100ug)
THOC7 (THO complex 7 homolog (Drosophila) ) Blocking Peptide (the C terminal of THOC7)(100ug)

THOC7 (THO complex 7 homolog (Drosophila) ) Blocking Peptide (the C terminal of THOC7)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-THOC7 Antibody (ARP67323_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67323
Size: 100ug
Weight: 22kDa
Gene: 80145
Format: Lyophilized powder
Target: THOC7 is a component of the THO subcomplex of the TREX complex. The TREX complex specifically associates with spliced mRNA and not with unspliced pre-mRNA. It is recruited to spliced mRNAs by a transcription-independent mechanism. Binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export. The recruitment occurs via an interaction between ALYREF/THOC4 and the cap-binding protein NCBP1. DDX39B functions as a bridge between ALYREF/THOC4 and the THO complex. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. The recruitment of the TREX complex to the intronless viral mRNA occurs via an interaction between KSHV ORF57 protein and ALYREF/THOC4.
Alternative names: FLJ23445; NIF3L1BP1; fSAP24
See Full Product Listings >